consumer genetic testing
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.
While the company's new 510(k) cuts down some of the burden, consumers are still advised to consult their healthcare provider before making any changes to their treatments.
The cuts equal a 14% reduction in the consumer genomic company's workforce.
While the test offers information on whether or not certain treatments may be effective, the regulatory agency stressed that the results should never be used in care decisions.
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports.
A group of consumer genetic and personal genomic testing companies have released a set of best practices for handling consumers’ personal genetic data.